Results 251 to 260 of about 1,399,233 (310)

Editorial: The role of platelet derivatives in regenerative medicine. [PDF]

Front Cell Dev Biol
Stanca E, Damiano F, Palermo A.
europepmc   +1 more source

Environmental endocrine disruptors in cardio-oncology: emerging modifiers of cardiovascular vulnerability in patients with cancer. [PDF]

Cardiooncology
Quagliariello V, Berretta M, D'Aiuto G, Bisceglia I, Barbato M, Del Toro B, Santagata J, Canale ML, Paccone A, Inno A, D'Ambrosio C, Oliva S, Dessalvi CC, Di Matola T, Gabrielli D, Fabiani I, Pagliani L, Iliescu CA, Borowiec A, Maurea N.   +19 more
europepmc   +1 more source

Advances in nanotechnology applied to natural products. [PDF]

Beilstein J Nanotechnol
Dourado D, Formiga FR, Alencar ÉDN, Reynaud F.   +3 more
europepmc   +1 more source

Integrated Protection of Stored Products: Proceedings of the meeting at Volos (Greece), 4-7. July, 2011

, 2012
Athanassiou, Christos G., International Organization for Biological Control of Noxious Animals and Plants Working Group Integrated Protection of Stored Products   +1 more
core  

Some of the next articles are maybe not open access.

Related searches:

Interferons in Malignancy: Biological Products or Biological Response Modifiers?

Journal of the National Cancer Institute, 1988
Susan E Krown, Krown Susan E
exaly   +3 more sources

The regulation of biological products

European Journal of Clinical Microbiology & Infectious Diseases, 1990
The purpose of regulations for biological products is the same as that for any other medicinal or related products: the protection of recipients of the products. The entry into the age of molecular biology with its attendant development and manufacturing technology has placed new demands on regulatory agencies and related industry personnel.
openaire   +2 more sources

Digital-to-biological converter for on-demand production of biologics

Nature Biotechnology, 2017
Manufacturing processes for biological molecules in the research laboratory have failed to keep pace with the rapid advances in automization and parellelization. We report the development of a digital-to-biological converter for fully automated, versatile and demand-based production of functional biologics starting from DNA sequence information ...
Kent S, Boles, Krishna, Kannan, John, Gill, Martina, Felderman, Heather, Gouvis, Bolyn, Hubby, Kurt I, Kamrud, J Craig, Venter, Daniel G, Gibson   +8 more
openaire   +2 more sources

On the interchangeability of biologic drug products

Statistics in Medicine, 2012
Interchangeability of drug products has very different features with small molecules and with biologicals. With small‐molecule drugs, a statement of bioequivalence generally indicates therapeutic equivalence and interchangeability. In contrast, with the much more sensitive and complicated biological drugs, a declaration of biosimilarity emphatically ...
Endrenyi L, Chang C, Chow SC, Tóthfalusi László   +3 more
openaire   +4 more sources